Baird Medical Investment Holdings Limited (BDMD)
NASDAQ: BDMD · Real-Time Price · USD
1.150
-0.100 (-8.00%)
At close: Jan 16, 2026, 4:00 PM EST
1.160
+0.010 (0.87%)
After-hours: Jan 16, 2026, 4:51 PM EST
BDMD Market Cap
BDMD has a market cap or net worth of $42.23 million as of January 16, 2026. Its market cap has decreased by -84.47% in one year.
Market Cap
42.23M
Enterprise Value
62.29M
1-Year Change
-84.47%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since December 16, 2021, BDMD's market cap has decreased from $278.01M to $42.23M, a decrease of -84.81%. That is a compound annual growth rate of -36.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 42.23M | -15.44% |
| Dec 31, 2025 | 49.95M | -81.63% |
| Dec 31, 2024 | 271.92M | 219.30% |
| Dec 26, 2023 | 85.16M | -71.13% |
| Dec 29, 2022 | 294.98M | 4.06% |
| Dec 30, 2021 | 283.48M | 1.96% |
| Dec 16, 2021 | 278.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |